Furthermore, an essential role for PMS2 was inconsistent with the demonstration that in a mouse model of DM1, loss of PMS2 resulted in a loss of only ~ 50% of expansions in the somatic tissues examined12, while in a mouse model of FRDA, PMS2 actually suppressed expansions13. The gene discussed is PMS2; the disease is myotonic dystrophy type 1.